Pharma channel feed

Cana­di­an plant-based vac­cine de­vel­op­er Med­ica­go shut­ters months af­ter lay­offs

3 years ago
People

Gilead boasts its best growth since 2015 de­spite plung­ing sales of Covid treat­ment

3 years ago

Eli Lil­ly touts sky­rock­et­ing Moun­jaro pre­scrip­tions even as it re­ports an over­all slump in 2022 rev­enue

3 years ago

Bris­tol My­ers turns at­ten­tion to new prod­ucts in wake of Revlim­id patent loss

3 years ago

Roche writes off $3B+ in pipeline as­sets, $750M for Spark-ac­quired gene ther­a­pies

3 years ago

Mer­ck’s Keytru­da nears $21B in sales, dou­bles down on com­bo tri­als

3 years ago

J&J’s Janssen lays off em­ploy­ees at Penn­syl­va­nia, New Jer­sey sites

3 years ago
People

J&J’s Janssen ‘Blue Jack­et’ fash­ion show re­turns to run­way for prostate can­cer aware­ness

3 years ago
Marketing

BioN­Tech opens new plas­mid DNA man­u­fac­tur­ing fa­cil­i­ty in Ger­many

3 years ago
Cell/Gene Tx
Manufacturing

In­com­ing Roche CEO builds out his top team, tap­ping Genen­tech vet to lead phar­ma di­vi­sion

3 years ago
People

FDA ap­proves GSK's ane­mia drug with safe­ty warn­ing — af­ter bat­ting back sim­i­lar drugs

3 years ago
FDA+

Af­ter a busy year of build­outs, Ther­mo Fish­er sets plans for growth in 2023

3 years ago
Manufacturing

GSK dou­bles down on vac­cines, HIV meds as CEO Em­ma Walm­s­ley touts 'land­mark' 2022

3 years ago

City of Hope re­brands ac­quired Can­cer Treat­ment Cen­ters of Amer­i­ca net­work un­der its own name

3 years ago
Marketing

No­vo Nordisk notch­es big GLP-1 sales amid re­bound­ing sup­plies, but cau­tions on fu­ture 'pe­ri­od­ic con­straints'

3 years ago
Marketing

Go­ing block­buster hunt­ing, Vas Narasimhan out­lines vi­sion for ‘pure-play’ No­var­tis

3 years ago

Pfiz­er brings Ibrance to new sub­set of breast can­cer pa­tients, re­gard­less of menopausal sta­tus

3 years ago
FDA+

2022 was about ex­e­cu­tion. Now will Am­gen's growth strat­e­gy prove its worth?

3 years ago

New com­peti­tors push Sanofi to of­fer vol­un­tary re­tire­ment pack­ages at two In­di­an sites

3 years ago
People
Manufacturing

Pfiz­er's Al­bert Bourla spells out 'tran­si­tion year' for Covid prod­ucts, with sales ex­pect­ed to reach a low point

3 years ago

Pfiz­er scores high­est spend­ing dur­ing NFL sea­son among phar­ma ad­ver­tis­ers — iS­pot analy­sis

3 years ago
Marketing

Covid pub­lic health emer­gen­cies to end in May, but FDA's EUA au­thor­i­ty will con­tin­ue

3 years ago
FDA+
Coronavirus

Mar­ket­ingRx roundup: Pub­li­cis takes can­cer work­place ef­fort to Su­per Bowl; Phar­ma ad­ver­tis­ers still spend big on TV

3 years ago
Marketing

Vec­tor Bio­Med launch­es with $15M to pro­duce back­logged CAR-T com­po­nent

3 years ago
Financing
Startups
First page Previous page 146147148149150151152 Next page Last page
A service from the Financial Times